
About
YD BioLabs develops enzymatic nucleic acid synthesis, labeling, and modification technologies for research and commercial customers. It offers services for oligonucleotide labeling, antibody–oligonucleotide conjugation, enzyme CDMO, and collaborative development. The company is based in Zhubei City, Hsinchu County, Taiwan.
Services
Oligonucleotide Modification
Provides enzymatic, site-specific oligonucleotide labeling for probes, barcodes, and antibody conjugates with 5', 3', or dual-end modifications.
Antibody–Oligonucleotide Conjugation (AOC)
Develops customizable antibody–oligo conjugates using a proprietary DNA linker platform for diagnostic and therapeutic applications.
Enzyme CDMO
Designs, engineers, expresses, and purifies enzymes for nucleic acid diagnostics, synthesis, and labeling.
Collaborative Development
Co-develops nucleic acid tools and platforms, including assay development, probe design, custom enzyme applications, and pilot testing.
- Turnaround
- Complete labeling reactions within hours
- What to send
- Project details for AOC development, including payload, target, and application
Capabilities
- Assays and studies
- Antibodies · Oligonucleotides · NGS · HPLC · qPCR · dPCR · NGS target enrichment · In situ hybridization · FRET · TaqMan assays · SNP detection · Isothermal amplification
1 more
Multiplexing - Scale and capacity
- Low-to-medium throughput projects · Commercial-scale production
- Therapeutic areas
- Molecular diagnostics · Therapeutics · Basic research · Environmental protection
Instruments and platforms
- HPLC
- Electrophoresis
Modalities and species
- Modalities
- Antibody · ADC · Oligonucleotide
Company
- Type
- CDMO
- Founded
- 2019
Locations
- Based in
- Zhubei, Taiwan
- Sites
- Zhubei City, Hsinchu County, Taiwan (R.O.C.) · Hsinchu, Taiwan
- Serves
- worldwide
Contacts
- General enquiry
- info@ydbiolabs.com on their site
Similar labs
Work here? Claim this listing